Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
636 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (3%) | |
| Resolved: | 557 (88%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (29%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SIMVASTATIN | 80MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54798 |
| SIMVASTATIN | 10MG | TABLET | Resolved | 2018-07-09 | 2021-05-06 | 54802 |
| SNS-ASA EC | 80MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-16 | 2023-09-10 | 187303 |
| SNS-ASA EC | 80MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-03-10 | 2025-03-11 | 252288 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2019-06-10 | 2019-10-10 | 86061 |
| SOLIFENACIN | 10MG | TABLET | Resolved | 2019-06-10 | 2019-10-10 | 86064 |
| SOLIFENACIN | 5MG | TABLET | Avoided shortage | 2022-04-05 | 2022-10-20 | 157901 |
| SOLIFENACIN | 10MG | TABLET | Resolved | 2023-07-31 | 2024-02-12 | 200459 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2023-09-26 | 2023-12-01 | 205212 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2024-01-30 | 2024-06-27 | 217809 |
| SOLIFENACIN | 10MG | TABLET | Resolved | 2024-02-26 | 2024-03-08 | 220673 |
| SOLIFENACIN | 10MG | TABLET | Resolved | 2024-05-28 | 2024-09-05 | 228966 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2024-08-01 | 2024-10-01 | 234204 |
| SOLIFENACIN | 10MG | TABLET | Actual shortage | 2024-09-09 | 2024-09-10 | 236973 |
| SOLIFENACIN | 5MG | TABLET | Resolved | 2025-01-13 | 2025-01-30 | 247552 |
| SUMATRIPTAN | 50MG | TABLET | Actual shortage | 2025-08-11 | 2025-10-08 | 265013 |
| TADALAFIL | 20MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200474 |
| TADALAFIL | 5MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200477 |
| TADALAFIL | 20MG | TABLET | Resolved | 2025-04-07 | 2025-09-26 | 254379 |
| TADALAFIL | 10MG | TABLET | Resolved | 2025-05-28 | 2025-10-16 | 258589 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |